ECSP982806A - ACE INHIBITOR-MMP INHIBITOR COMBINATIONS - Google Patents

ACE INHIBITOR-MMP INHIBITOR COMBINATIONS

Info

Publication number
ECSP982806A
ECSP982806A ECSP982806A ECSP982806A EC SP982806 A ECSP982806 A EC SP982806A EC SP982806 A ECSP982806 A EC SP982806A EC SP982806 A ECSP982806 A EC SP982806A
Authority
EC
Ecuador
Prior art keywords
inhibitor
combinations
mmp
ace
ace inhibitor
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Peterson Joseph Thomas Jr
Milton Lethan Pressler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982806 priority Critical patent/ECSP982806A/en
Publication of ECSP982806A publication Critical patent/ECSP982806A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Las combinaciones de inhibidores de ACE e inhibidores de MMP son útiles para retardar y revertir el proceso de la fibrosis, dilatación ventricular e insuficiencia cardiaca en mamíferos.Combinations of ACE inhibitors and MMP inhibitors are useful for delaying and reversing the process of fibrosis, ventricular dilation, and heart failure in mammals.

ECSP982806 1998-12-22 1998-12-22 ACE INHIBITOR-MMP INHIBITOR COMBINATIONS ECSP982806A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982806 ECSP982806A (en) 1998-12-22 1998-12-22 ACE INHIBITOR-MMP INHIBITOR COMBINATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982806 ECSP982806A (en) 1998-12-22 1998-12-22 ACE INHIBITOR-MMP INHIBITOR COMBINATIONS

Publications (1)

Publication Number Publication Date
ECSP982806A true ECSP982806A (en) 1999-05-17

Family

ID=42043723

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982806 ECSP982806A (en) 1998-12-22 1998-12-22 ACE INHIBITOR-MMP INHIBITOR COMBINATIONS

Country Status (1)

Country Link
EC (1) ECSP982806A (en)

Similar Documents

Publication Publication Date Title
UY25321A1 (en) MMP ACE-INHIBITOR INHIBITOR COMBINATIONS
NO963860L (en) Isoprenyl transferase inhibitors
BR9714385A (en) Method for treating and preventing heart failure and ventricular dilation
UY26380A1 (en) FAB I INHIBITORS
TR200103216T2 (en) Pyrimidinone compositions
DE69916792D1 (en) Potassium channel blockers
ATE250571T1 (en) POTASSIUM CHANNEL BLOCKERS
NO20054369L (en) Use of an IBAT inhibitor for the treatment and prophylaxis of constipation
TR200102711T2 (en) Anticonvulsant derivatives for use in the treatment of crisis headaches
ES2062812T3 (en) ENZYMATIC DETERGENT COMPOSITION AND METHOD FOR STABILIZING ENZYMES.
TR199802676A2 (en) Method for the treatment and prevention of tumors, tumor-related diseases and cacaxia.
BR0215405A (en) Compositions and processes of use of collajolie
NO992492L (en) Benzamidoaldehydes and their use as cysteine protease inhibitors
NO20005928D0 (en) Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
DE60123276D1 (en) PIPERAZINE DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
NO20034094L (en) Compositions comprising an anti-diarrheal agent and an epothilone or epothilone derivative
NO20005237D0 (en) Heterocyclic substituted amides used as calpain inhibitors
MX9207449A (en) INHIBITORS OF THE PROTEOLYTIC ENZYME DERIVED FROM SACARINE.
NO20003828L (en) 2,3,4,5-tetrahydro-1H- [1,4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
DK1178726T3 (en) Aqueous solution for preserving tissues and organs
ES2167678T3 (en) TREATMENT AND PROFILAXIS OF PANCREATITIS.
ES2184341T3 (en) A METHOD FOR THE PREVENTION AND TREATMENT OF Myocardium Dysfunction.
AR022321A1 (en) USEFUL ANTI-CONVULSIVE DERIVATIVES FOR THE TREATMENT OF TRANSFORMED MIGRANE
NO20021007L (en) Substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors